Quadrant Capital Group’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,945
| Closed | -$8.81K | – | 1882 |
|
|
2025
Q1 | $8.81K | Buy |
1,945
+1,529
| +368% | +$6.93K | ﹤0.01% | 2245 |
|
|
2024
Q4 | $2.94K | Hold |
416
| – | – | ﹤0.01% | 2441 |
|
|
2024
Q3 | $3.39K | Sell |
416
-1,390
| -77% | -$11.3K | ﹤0.01% | 2397 |
|
|
2024
Q2 | $11.5K | Buy |
1,806
+1,468
| +434% | +$9.38K | ﹤0.01% | 2070 |
|
|
2024
Q1 | $2.55K | Hold |
338
| – | – | ﹤0.01% | 2463 |
|
|
2023
Q4 | $3.13K | Sell |
338
-160
| -32% | -$1.48K | ﹤0.01% | 2387 |
|
|
2023
Q3 | $5.04K | Sell |
498
-1,273
| -72% | -$12.9K | ﹤0.01% | 2172 |
|
|
2023
Q2 | $22.1K | Buy |
1,771
+97
| +6% | +$1.21K | ﹤0.01% | 1668 |
|
|
2023
Q1 | $19.5K | Sell |
1,674
-8
| -0.5% | -$93 | ﹤0.01% | 1710 |
|
|
2022
Q4 | $17.9K | Buy |
1,682
+789
| +88% | +$8.39K | ﹤0.01% | 1705 |
|
|
2022
Q3 | $9K | Sell |
893
-176
| -16% | -$1.77K | ﹤0.01% | 1924 |
|
|
2022
Q2 | $15K | Buy |
1,069
+995
| +1,345% | +$14K | ﹤0.01% | 1438 |
|
|
2022
Q1 | $2K | Buy |
+74
| New | +$2K | ﹤0.01% | 2152 |
|
|
2021
Q3 | – | Sell |
-4
| Closed | – | – | 2554 |
|
|
2021
Q2 | $0 | Buy |
+4
| New | – | ﹤0.01% | 2469 |
|